Package 63323-691-30

{"route": ["ORAL", "RESPIRATORY (INHALATION)"], "spl_id": "da00a3b4-d7e8-464b-a13f-422b445de8ee", "openfda": {"nui": ["N0000175429", "N0000175961", "N0000008867", "N0000175960", "N0000175776", "N0000175547"], "unii": ["WYQ7N0BPYC"], "rxcui": ["307718", "307719"], "spl_set_id": ["75b48fab-cef6-465c-a1e0-d085b3988bc4"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Glutathione Concentration [PE]"], "pharm_class_epc": ["Antidote [EPC]", "Antidote for Acetaminophen Overdose [EPC]", "Mucolytic [EPC]"], "pharm_class_moa": ["Reduction Activity [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 VIAL in 1 CARTON (63323-691-30)  / 30 mL in 1 VIAL (63323-691-22)", "package_ndc": "63323-691-30", "marketing_start_date": "20140331"}], "brand_name": "Acetylcysteine", "product_id": "63323-691_da00a3b4-d7e8-464b-a13f-422b445de8ee", "dosage_form": "SOLUTION", "pharm_class": ["Antidote [EPC]", "Antidote for Acetaminophen Overdose [EPC]", "Decreased Respiratory Secretion Viscosity [PE]", "Increased Glutathione Concentration [PE]", "Mucolytic [EPC]", "Reduction Activity [MoA]"], "product_ndc": "63323-691", "generic_name": "ACETYLCYSTEINE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acetylcysteine", "active_ingredients": [{"name": "ACETYLCYSTEINE", "strength": "100 mg/mL"}], "application_number": "ANDA204674", "marketing_category": "ANDA", "marketing_start_date": "20140331", "listing_expiration_date": "20261231"}